Lilly announces new biotechnology investment – CSL Recruitment
By Dr. Matthew Watson
 InPharm | Lilly announces new biotechnology investment CSL Recruitment Lilly is to create more clinical research jobs worldwide via a new multimillion-dollar investment in its biotechnology capabilities. The pharmaceutical company has announced plans to undertake new drug development projects and appoint additional ... Lilly announces new investment in biotechnologyZenopa Eli Lilly to strengthen biotechnology capabilitiesPharmaceutical Business Review Lilly to invest millions to boost biotechnology researchMedReps (subscription) Pharma Times -North County Times (blog) -Indianapolis Star all 423 news articles » |
Uncategorized
Comments Off on Lilly announces new biotechnology investment – CSL Recruitment |
July 3rd, 2011
This author published 5912 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research